Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMHOA trial of intramuscular methylprednisolone for hand osteoarthritis
NL-OMON59855Phase 3Not yet recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylprednisolone in hand osteoarthritis (3 arms), sponsored by Sint Maartenskliniek. Primary endpoint: Primary efficacy endpoint. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on NL-OMON59855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59855.